In sub-Saharan Africa, 1 in 6 cancer medications found to be defective
Serious quality defects were found in a significant number of cancer medications from sub-Saharan Africa,…
Browsing: Featured
A photodynamic nanohybrid system reverses hypoxia and augment anti-primary and metastatic tumour efficacy of immunotherapy
This new article publication from Acta Pharmaceutica Sinica B discusses how a photodynamic nanohybrid system reverses hypoxia…
Bowel cancer survivors at higher risk of subsequent cancers, statistics show
A Flinders University study shows that bowel cancer survivors face an elevated risk of developing…
Pharaoh’s curse: Turning toxic fungus into anti-cancer compound
Researchers have turned a deadly fungus into a potent cancer-fighting compound. After isolating a new…
Institute enhances immunotherapy for difficult-to-treat brain tumours with gut microbiota
Advanced treatments, known as immunotherapies that activate T cells—our body’s immune cells—to eliminate cancer cells,…
AI-driven TIL quantification shows superior consistency and strong prognostic value in melanoma
A new study published in JAMA Network Open has found that artificial intelligence (AI)–assisted assessment…
New ctDNA blood test shows high accuracy for colorectal cancer screening in average-risk adults
A landmark multicentre diagnostic study published in JAMA has evaluated an investigational circulating tumour DNA…
QBiotics reports 80% objective response rate in injected tumours in Stage I of Phase IIA soft tissue sarcoma trial
QBiotics Group Limited (QBiotics) announced final efficacy and safety results from the first stage of…
Improving the efficiency of glioblastoma immunotherapy with gut microbiota
Immunotherapies that activate T cells to eliminate cancer cells have shown limited efficacy as standalone…
Immunotherapy shows promise in aggressive gynaecological clear cell cancers
Australian-led trial delivers encouraging results. A landmark Australian-led phase 2 clinical trial has delivered promising…